What LAVA Therapeutics NV's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 15 |
| Total trades | 0 | 19 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 6,971,226 |
| Net activity | +0 | −6,971,226 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Hurly Stephen A | Chief Executive Officer | Nov 13 | Disposition to Issuer · D | −5,000 | — | — | 0 |
| Wilson Karen J | Director | Nov 13 | Disposition to Issuer · D | −10,000 | — | — | 0 |
| Powell Fred M | Chief Financial Officer | Nov 13 | Disposition to Issuer · D | −65,000 | — | — | 0 |
| Dhingra Kapil | Director | Nov 13 | Disposition to Issuer · D | −30,000 | — | — | 0 |
| Cooperatieve Gilde Healthcare Iv U.a. | 10% owner | Oct 17 | Open-market sale · S | −1,181,131 | $1.47 | −$1.74M | 2,947,781 |
| Cooperatieve Gilde Healthcare Iv U.a. | 10% owner | Oct 16 | Open-market sale · S | −690,239 | $1.49 | −$1.03M | 4,128,912 |
| Cooperatieve Gilde Healthcare Iv U.a. | 10% owner | Oct 14 | Open-market sale · S | −227,341 | $1.51 | −$343K | 5,019,151 |
| Cooperatieve Gilde Healthcare Iv U.a. | 10% owner | Oct 13 | Open-market sale · S | −47,686 | $1.54 | −$73.4K | 5,246,492 |
| Cooperatieve Gilde Healthcare Iv U.a. | 10% owner | Oct 10 | Open-market sale · S | −49,869 | $1.55 | −$77.3K | 5,294,178 |
| Cooperatieve Gilde Healthcare Iv U.a. | 10% owner | Oct 09 | Open-market sale · S | −48,169 | $1.56 | −$75.1K | 5,344,047 |
| Cooperatieve Gilde Healthcare Iv U.a. | 10% owner | Oct 08 | Open-market sale · S | −28,954 | $1.57 | −$45.5K | 5,392,216 |
| Versant Venture Capital VI, L.p. | 10% owner | Sep 19 | Open-market sale · S | −532,870 | $1.40 | −$747K | 0 |
| Versant Venture Capital VI, L.p. | 10% owner | Sep 19 | Open-market sale · S | −2,370,533 | $1.40 | −$3.32M | 0 |
| Versant Venture Capital VI, L.p. | 10% owner | Sep 18 | Open-market sale · S | −228,791 | $1.44 | −$330K | 532,870 |
| Versant Venture Capital VI, L.p. | 10% owner | Sep 18 | Open-market sale · S | −366,111 | $1.44 | −$528K | 2,370,533 |
| Versant Venture Capital VI, L.p. | 10% owner | Sep 17 | Open-market sale · S | −226,726 | $1.49 | −$338K | 761,661 |
| Versant Venture Capital VI, L.p. | 10% owner | Sep 17 | Open-market sale · S | −362,806 | $1.49 | −$540K | 2,736,644 |
| Versant Venture Capital VI, L.p. | 10% owner | Sep 16 | Open-market sale · S | −192,293 | $1.53 | −$295K | 988,387 |
| Versant Venture Capital VI, L.p. | 10% owner | Sep 16 | Open-market sale · S | −307,707 | $1.53 | −$472K | 3,099,450 |
| Cooperatieve Gilde Healthcare Iv U.a. | 10% owner | Oct 20 | Open-market sale · S | −1,000,000 | $1.46 | −$1.46M | 1,947,781 |
Loading...